日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

The use of digital PCR to improve the application of quantitative molecular diagnostic methods for tuberculosis

利用数字PCR技术改进结核病定量分子诊断方法的应用

Devonshire, Alison S; O'Sullivan, Denise M; Honeyborne, Isobella; Jones, Gerwyn; Karczmarczyk, Maria; Pavšič, Jernej; Gutteridge, Alice; Milavec, Mojca; Mendoza, Pablo; Schimmel, Heinz; Van Heuverswyn, Fran; Gorton, Rebecca; Cirillo, Daniela Maria; Borroni, Emanuele; Harris, Kathryn; Barnard, Marinus; Heydenrych, Anthenette; Ndusilo, Norah; Wallis, Carole L; Pillay, Keshree; Barry, Thomas; Reddington, Kate; Richter, Elvira; Mozioğlu, Erkan; Akyürek, Sema; Yalçınkaya, Burhanettin; Akgoz, Muslum; Žel, Jana; Foy, Carole A; McHugh, Timothy D; Huggett, Jim F

Sensititre MycoTB plate compared to Bactec MGIT 960 for first- and second-line antituberculosis drug susceptibility testing in Tanzania: a call to operationalize MICs

在坦桑尼亚,Sensititre MycoTB 培养板与 Bactec MGIT 960 培养板在结核病一线和二线药物敏感性检测中的比较:呼吁将 MIC 检测方法付诸实践

Heysell, Scott K; Pholwat, Suporn; Mpagama, Stellah G; Pazia, Saumu J; Kumburu, Happy; Ndusilo, Norah; Gratz, Jean; Houpt, Eric R; Kibiki, Gibson S

Improvement in plasma drug activity during the early treatment interval among Tanzanian patients with multidrug-resistant tuberculosis

坦桑尼亚多重耐药结核病患者在早期治疗期间血浆药物活性改善

Ndusilo, Norah D; Heysell, Scott K; Mpagama, Stellah G; Gratz, Jean; Segesela, Farida H; Pazia, Saumu J; Wang, Xin-Qun; Houpt, Eric R; Kibiki, Gibson S

Plasma drug activity in patients on treatment for multidrug-resistant tuberculosis

接受多重耐药结核病治疗患者的血浆药物活性

Mpagama, Stellah G; Ndusilo, Norah; Stroup, Suzanne; Kumburu, Happiness; Peloquin, Charles A; Gratz, Jean; Houpt, Eric R; Kibiki, Gibson S; Heysell, Scott K

Plasma drug activity assay for treatment optimization in tuberculosis patients

结核病患者治疗优化中的血浆药物活性测定

Heysell, Scott K; Mtabho, Charles; Mpagama, Stellah; Mwaigwisya, Solomon; Pholwat, Suporn; Ndusilo, Norah; Gratz, Jean; Aarnoutse, Rob E; Kibiki, Gibson S; Houpt, Eric R